XORTX Therapeutics Inc (XRTX)

Currency in USD
2.0100
-0.1000(-4.74%)
Closed·
2.0224+0.0124(+0.62%)
·
XRTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.01002.0900
52 wk Range
1.72507.0500
Key Statistics
Prev. Close
2.11
Open
2.09
Day's Range
2.01-2.09
52 wk Range
1.725-7.05
Volume
12.61K
Average Volume (3m)
1.23M
1-Year Change
-56.3043%
Book Value / Share
0.92
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XRTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

XORTX Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
May 16, 2026
EPS / Forecast
-0.58 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

XRTX Income Statement

Compare XRTX to Peers and Sector

Metrics to compare
XRTX
Peers
Sector
Relationship
P/E Ratio
−1.3x−2.6x−0.4x
PEG Ratio
0.020.000.00
Price/Book
2.8x1.3x2.6x
Price / LTM Sales
-1.6x3.0x
Upside (Analyst Target)
-255.5%50.8%
Fair Value Upside
Unlock6.7%9.4%Unlock

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
188.77K10.91%379.43K
Public Companies & Retail Investors
1.54M89.09%3.10M
Total
1.73M100.00%3.48M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Lincoln Alternative Strategies Llc6.62%114,494230
Armistice Capital Master Fund Ltd.2.06%35,60672

People Also Watch

7.7300
ASTC
+2.66%
0.510
ATYR
-1.16%
34.50
ACHC
+2.65%
2.290
NXTS
-7.66%
3.80
SKYQ
-0.52%

FAQ

What Is the XORTX Therapeutics (XRTX) Stock Price Today?

The XORTX Therapeutics stock price today is 2.0100 USD.

What Stock Exchange Does XORTX Therapeutics Trade On?

XORTX Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for XORTX Therapeutics?

The stock symbol for XORTX Therapeutics is "XRTX."

What Is the XORTX Therapeutics Market Cap?

As of today, XORTX Therapeutics market cap is 3.6400M USD.

What Is XORTX Therapeutics's Earnings Per Share (TTM)?

The XORTX Therapeutics EPS (TTM) is -2.4961.

From a Technical Analysis Perspective, Is XRTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has XORTX Therapeutics Stock Split?

XORTX Therapeutics has split 3 times.

What is the current trading status of XORTX Therapeutics (XRTX)?

As of Jul 18, 2026, XORTX Therapeutics (XRTX) is trading at a price of 2.0100 USD, with a previous close of 2.1100 USD. The stock has fluctuated within a day range of 2.0100 USD to 2.0900 USD, while its 52-week range spans from 1.7250 USD to 7.0500 USD.

What Is the XRTX Premarket Price?

XRTX's last pre-market stock price is 2.1500 USD. The pre-market share volume is 2,900.0000, and the stock has decreased by 0.0400, or 1.9000%.

What Is the XRTX After Hours Price?

XRTX's last after hours stock price is 2.0224 USD, the stock has decreased by 0.0124, or 0.6200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.